This product is intended exclusively for laboratory and scientific research purposes
But after lowering a dose or stopping these medications altogether, the dreaded "food noise," or constant thoughts about food, usually returns
GLP-1-based therapies should be used with caution in pregnancy or breastfeeding, and the risk of hypoglycaemia is increased when these agents are used alongside insulin or sulfonylureas
Unlike GLP-1, PYY development did not benefit from later advances in long-acting formulations or exposure smoothing, leading to premature abandonment of an otherwise biologically compelling target
Okun The New England Journal of Medicines recent publication of a randomized study of a GLP-1 agonist originally designed for diabetes, but applied to Parkinson's disease, has led to a flurry of excitement and to a mountain of questions
At Blue Horizon, we believe that the best health decisions are made when you have the full clinical picture